Drägerwerk stock: mwb keeps EUR 135 target for Drägerwerk stock

Published on 10/23/2026 at 15:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter revenue hit EUR 851.00 million. Drägerwerk stock costs EUR 99.50 on October 23, 2026, up 1.12 percent versus the Xetra close.

Analyst target and earnings figures

mwb research maintained a EUR 135.00 target for Drägerwerk on October 15, 2026.
Third-quarter revenue reached EUR 851.00 million while EBIT fell to EUR 48.00 million.
Drägerwerk stock costs EUR 99.50 at Lang & Schwarz on October 23, 2026 at 5:06 p.m. CEST, 1.12 percent above the Xetra close of October 22, 2026 and 20.65 percent below the 52-week high.
Drägerwerk is scheduled to publish its third-quarter report on October 28, 2026.

Architekturvisualisierung eines modernen Medizintechnik-Forschungsgebäudes mit Glasfassade — Drägerwerk AG & Co. KGaA modernes Forschungsgebäude Medizintechnik Glasfassade Architekturrender Unternehmensanlage DE0005550636, Illustration mit AI erstellt.

Drägerwerk (ISIN DE0005550636) faces a EUR 135.00 price target from mwb research, which maintained its recommendation on October 15, 2026, putting the target 35.68 percent above the EUR 99.50 price. The assessment followed preliminary third-quarter figures that showed revenue growth but weaker operating profit, as 4investors reported on October 15, 2026. Drägerwerk stock was trading at EUR 99.50 at Lang & Schwarz on October 23, 2026 at 5:06 p.m. CEST, up 1.12 percent versus the Xetra close of October 22, 2026 at EUR 98.40.

Revenue rose as EBIT fell

Drägerwerk generated EUR 851.00 million of revenue in the third quarter of 2026, up 2.10 percent from the prior-year quarter. EBIT fell 15.00 percent to EUR 48.00 million, while the EBIT margin declined from 6.80 percent to 5.60 percent, according to 4investors.

The stock sits below its high

At EUR 99.50, the stock stood 20.65 percent below its 52-week high of EUR 125.40 and 50.76 percent above its 52-week low of EUR 66.00 on October 23, 2026. Trading volume was 8,324 shares, against an average volume of 22,607 shares. The market capitalization was EUR 1.9 billion and the price-to-earnings ratio was 10.88.

What does EUR 135 imply?

The mwb research target is EUR 35.50 above the Lang & Schwarz price. Drägerwerk's investor-relations page lists 2026 revenue growth guidance of 2.00 to 6.00 percent and an EBIT margin range of 5.00 to 7.50 percent, while the company reported a 6.70 percent EBIT margin for fiscal year 2025. The same page identifies medical and safety technology as the company's two principal markets and reports fiscal-year 2025 revenue of EUR 3.5 billion, as stated by Dräger.

Drägerwerk is scheduled to publish its third-quarter report on October 28, 2026, according to MarketScreener. The company confirmed 2026 guidance for currency-adjusted revenue growth of 2.00 to 6.00 percent and an EBIT margin of 6.00 to 8.00 percent in October 2026.